Your English writing platform
Discover LudwigSuggestions(5)
Exact(5)
The spin-off of the "non core" RBP business was flagged last October when the company announced a strategic review of the shrinking unit.
RBP, based in the US state of Virginia, generates nearly all its revenues from Suboxone, a heroin addiction treatment, but revenues have been shrinking as cheaper generic copies have come onto the market.
Analysts have valued RBP at up to £2.9bn or £4 a share, but say that information gaps prevent them from getting the full picture.
RBP could be worth £4 plus per Reckitt share but there are currently many information gaps (e.g. how much debt is assigned to it?) Further M&A is a possibility - the interest in Merck's OTC assets in April proved that Reckitt retains major ambitions.
Kapoor said he expected the listing of RBP to take place over the next 12 months, allowing the rest of the company "to focus on its core strategy to be a global leader in consumer health and hygiene".
Similar(2)
Cantor Fitzgerald was also positive: The announcement of positive top line results for the pivotal long acting depot formulation (RBP-6000) of buprenorphine further de-risks the Indivior investment case we believe and should provide longevity to the franchise which is currently dominated by the threatened Suboxone film franchise.
In a buy note Jefferies analysts said: Indivior has reported top-line data for its once-monthly injectable treatment for opioid use disorder, RBP-6000.
Write better and faster with AI suggestions while staying true to your unique style.
Since I tried Ludwig back in 2017, I have been constantly using it in both editing and translation. Ever since, I suggest it to my translators at ProSciEditing.

Justyna Jupowicz-Kozak
CEO of Professional Science Editing for Scientists @ prosciediting.com